カテゴリ： GlobalInfoResearch, 世界, 消費財/食品

世界ののど飴市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Nodoame Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO9338）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO9338
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：食品＆飲料
■ ページ数：109
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界ののど飴市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

のど飴市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界ののど飴の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

のど飴市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・薬用、食品

用途別セグメントは次のように区分されます。
・スーパー、ドラッグストア

世界ののど飴市場の主要な市場プレーヤーは以下のとおりです。
・Comvita、Vocalzone、Good Health、Kanro、UHA Mikakuto Co.,Ltd、RYUKAKUSAN Co.,Ltd.、Zirkulin、Ricola、Fisherman's Friend、Golden Throat Holdings Group Company Limited、Nin Jiom、Wong Lo Kat、Poon Goor Soe、Guilin Sanjin Pharmaceutical Company Limited

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、のど飴製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なのど飴メーカーの企業概要、2019年～2022年までののど飴の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なのど飴メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別のど飴の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までののど飴の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でののど飴市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびのど飴の産業チェーンを掲載しています。
・第13、14、15章では、のど飴の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- のど飴の概要
- 種類別分析（2017年vs2021年vs2028年）：薬用、食品
- 用途別分析（2017年vs2021年vs2028年）：スーパー、ドラッグストア
- 世界ののど飴市場規模・予測
- 世界ののど飴生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Comvita、Vocalzone、Good Health、Kanro、UHA Mikakuto Co.,Ltd、RYUKAKUSAN Co.,Ltd.、Zirkulin、Ricola、Fisherman's Friend、Golden Throat Holdings Group Company Limited、Nin Jiom、Wong Lo Kat、Poon Goor Soe、Guilin Sanjin Pharmaceutical Company Limited
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：薬用、食品
・用途別分析2017年-2028年：スーパー、ドラッグストア
・のど飴の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・のど飴のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・のど飴のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・のど飴の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・のど飴の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Nodoame market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nodoame market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Supermarket accounting for % of the Nodoame global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Medicinal segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nodoame include Comvita, Vocalzone, Good Health, Kanro, and UHA Mikakuto Co.,Ltd, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nodoame market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Medicinal
Food
Market segment by Application can be divided into
Supermarket
Drugstore
The key market players for global Nodoame market are listed below:
Comvita
Vocalzone
Good Health
Kanro
UHA Mikakuto Co.,Ltd
RYUKAKUSAN Co.,Ltd.
Zirkulin
Ricola
Fisherman’s Friend
Golden Throat Holdings Group Company Limited
Nin Jiom
Wong Lo Kat
Poon Goor Soe
Guilin Sanjin Pharmaceutical Company Limited
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nodoame product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nodoame, with price, sales, revenue and global market share of Nodoame from 2019 to 2022.
Chapter 3, the Nodoame competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nodoame breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nodoame market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nodoame.
Chapter 13, 14, and 15, to describe Nodoame sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Nodoame Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nodoame Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Medicinal
1.2.3 Food
1.3 Market Analysis by Application
1.3.1 Overview: Global Nodoame Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Supermarket
1.3.3 Drugstore
1.4 Global Nodoame Market Size & Forecast
1.4.1 Global Nodoame Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nodoame Sales in Volume (2017-2028)
1.4.3 Global Nodoame Price (2017-2028)
1.5 Global Nodoame Production Capacity Analysis
1.5.1 Global Nodoame Total Production Capacity (2017-2028)
1.5.2 Global Nodoame Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nodoame Market Drivers
1.6.2 Nodoame Market Restraints
1.6.3 Nodoame Trends Analysis
2 Manufacturers Profiles
2.1 Comvita
2.1.1 Comvita Details
2.1.2 Comvita Major Business
2.1.3 Comvita Nodoame Product and Services
2.1.4 Comvita Nodoame Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Vocalzone
2.2.1 Vocalzone Details
2.2.2 Vocalzone Major Business
2.2.3 Vocalzone Nodoame Product and Services
2.2.4 Vocalzone Nodoame Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Good Health
2.3.1 Good Health Details
2.3.2 Good Health Major Business
2.3.3 Good Health Nodoame Product and Services
2.3.4 Good Health Nodoame Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Kanro
2.4.1 Kanro Details
2.4.2 Kanro Major Business
2.4.3 Kanro Nodoame Product and Services
2.4.4 Kanro Nodoame Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 UHA Mikakuto Co.,Ltd
2.5.1 UHA Mikakuto Co.,Ltd Details
2.5.2 UHA Mikakuto Co.,Ltd Major Business
2.5.3 UHA Mikakuto Co.,Ltd Nodoame Product and Services
2.5.4 UHA Mikakuto Co.,Ltd Nodoame Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 RYUKAKUSAN Co.,Ltd.
2.6.1 RYUKAKUSAN Co.,Ltd. Details
2.6.2 RYUKAKUSAN Co.,Ltd. Major Business
2.6.3 RYUKAKUSAN Co.,Ltd. Nodoame Product and Services
2.6.4 RYUKAKUSAN Co.,Ltd. Nodoame Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Zirkulin
2.7.1 Zirkulin Details
2.7.2 Zirkulin Major Business
2.7.3 Zirkulin Nodoame Product and Services
2.7.4 Zirkulin Nodoame Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Ricola
2.8.1 Ricola Details
2.8.2 Ricola Major Business
2.8.3 Ricola Nodoame Product and Services
2.8.4 Ricola Nodoame Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Fisherman’s Friend
2.9.1 Fisherman’s Friend Details
2.9.2 Fisherman’s Friend Major Business
2.9.3 Fisherman’s Friend Nodoame Product and Services
2.9.4 Fisherman’s Friend Nodoame Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Golden Throat Holdings Group Company Limited
2.10.1 Golden Throat Holdings Group Company Limited Details
2.10.2 Golden Throat Holdings Group Company Limited Major Business
2.10.3 Golden Throat Holdings Group Company Limited Nodoame Product and Services
2.10.4 Golden Throat Holdings Group Company Limited Nodoame Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Nin Jiom
2.11.1 Nin Jiom Details
2.11.2 Nin Jiom Major Business
2.11.3 Nin Jiom Nodoame Product and Services
2.11.4 Nin Jiom Nodoame Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Wong Lo Kat
2.12.1 Wong Lo Kat Details
2.12.2 Wong Lo Kat Major Business
2.12.3 Wong Lo Kat Nodoame Product and Services
2.12.4 Wong Lo Kat Nodoame Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Poon Goor Soe
2.13.1 Poon Goor Soe Details
2.13.2 Poon Goor Soe Major Business
2.13.3 Poon Goor Soe Nodoame Product and Services
2.13.4 Poon Goor Soe Nodoame Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Guilin Sanjin Pharmaceutical Company Limited
2.14.1 Guilin Sanjin Pharmaceutical Company Limited Details
2.14.2 Guilin Sanjin Pharmaceutical Company Limited Major Business
2.14.3 Guilin Sanjin Pharmaceutical Company Limited Nodoame Product and Services
2.14.4 Guilin Sanjin Pharmaceutical Company Limited Nodoame Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Nodoame Breakdown Data by Manufacturer
3.1 Global Nodoame Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nodoame Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nodoame
3.4 Market Concentration Rate
3.4.1 Top 3 Nodoame Manufacturer Market Share in 2021
3.4.2 Top 6 Nodoame Manufacturer Market Share in 2021
3.5 Global Nodoame Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nodoame Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nodoame Market Size by Region
4.1.1 Global Nodoame Sales in Volume by Region (2017-2028)
4.1.2 Global Nodoame Revenue by Region (2017-2028)
4.2 North America Nodoame Revenue (2017-2028)
4.3 Europe Nodoame Revenue (2017-2028)
4.4 Asia-Pacific Nodoame Revenue (2017-2028)
4.5 South America Nodoame Revenue (2017-2028)
4.6 Middle East and Africa Nodoame Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Nodoame Sales in Volume by Type (2017-2028)
5.2 Global Nodoame Revenue by Type (2017-2028)
5.3 Global Nodoame Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Nodoame Sales in Volume by Application (2017-2028)
6.2 Global Nodoame Revenue by Application (2017-2028)
6.3 Global Nodoame Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Nodoame Sales by Type (2017-2028)
7.2 North America Nodoame Sales by Application (2017-2028)
7.3 North America Nodoame Market Size by Country
7.3.1 North America Nodoame Sales in Volume by Country (2017-2028)
7.3.2 North America Nodoame Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Nodoame Sales by Type (2017-2028)
8.2 Europe Nodoame Sales by Application (2017-2028)
8.3 Europe Nodoame Market Size by Country
8.3.1 Europe Nodoame Sales in Volume by Country (2017-2028)
8.3.2 Europe Nodoame Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Nodoame Sales by Type (2017-2028)
9.2 Asia-Pacific Nodoame Sales by Application (2017-2028)
9.3 Asia-Pacific Nodoame Market Size by Region
9.3.1 Asia-Pacific Nodoame Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nodoame Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Nodoame Sales by Type (2017-2028)
10.2 South America Nodoame Sales by Application (2017-2028)
10.3 South America Nodoame Market Size by Country
10.3.1 South America Nodoame Sales in Volume by Country (2017-2028)
10.3.2 South America Nodoame Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nodoame Sales by Type (2017-2028)
11.2 Middle East & Africa Nodoame Sales by Application (2017-2028)
11.3 Middle East & Africa Nodoame Market Size by Country
11.3.1 Middle East & Africa Nodoame Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nodoame Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Nodoame and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nodoame
12.3 Nodoame Production Process
12.4 Nodoame Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nodoame Typical Distributors
13.3 Nodoame Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Nodoame Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Nodoame Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Comvita Basic Information, Manufacturing Base and Competitors
Table 4. Comvita Major Business
Table 5. Comvita Nodoame Product and Services
Table 6. Comvita Nodoame Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Vocalzone Basic Information, Manufacturing Base and Competitors
Table 8. Vocalzone Major Business
Table 9. Vocalzone Nodoame Product and Services
Table 10. Vocalzone Nodoame Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Good Health Basic Information, Manufacturing Base and Competitors
Table 12. Good Health Major Business
Table 13. Good Health Nodoame Product and Services
Table 14. Good Health Nodoame Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Kanro Basic Information, Manufacturing Base and Competitors
Table 16. Kanro Major Business
Table 17. Kanro Nodoame Product and Services
Table 18. Kanro Nodoame Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. UHA Mikakuto Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 20. UHA Mikakuto Co.,Ltd Major Business
Table 21. UHA Mikakuto Co.,Ltd Nodoame Product and Services
Table 22. UHA Mikakuto Co.,Ltd Nodoame Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. RYUKAKUSAN Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. RYUKAKUSAN Co.,Ltd. Major Business
Table 25. RYUKAKUSAN Co.,Ltd. Nodoame Product and Services
Table 26. RYUKAKUSAN Co.,Ltd. Nodoame Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Zirkulin Basic Information, Manufacturing Base and Competitors
Table 28. Zirkulin Major Business
Table 29. Zirkulin Nodoame Product and Services
Table 30. Zirkulin Nodoame Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Ricola Basic Information, Manufacturing Base and Competitors
Table 32. Ricola Major Business
Table 33. Ricola Nodoame Product and Services
Table 34. Ricola Nodoame Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Fisherman's Friend Basic Information, Manufacturing Base and Competitors
Table 36. Fisherman's Friend Major Business
Table 37. Fisherman's Friend Nodoame Product and Services
Table 38. Fisherman's Friend Nodoame Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Golden Throat Holdings Group Company Limited Basic Information, Manufacturing Base and Competitors
Table 40. Golden Throat Holdings Group Company Limited Major Business
Table 41. Golden Throat Holdings Group Company Limited Nodoame Product and Services
Table 42. Golden Throat Holdings Group Company Limited Nodoame Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Nin Jiom Basic Information, Manufacturing Base and Competitors
Table 44. Nin Jiom Major Business
Table 45. Nin Jiom Nodoame Product and Services
Table 46. Nin Jiom Nodoame Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Wong Lo Kat Basic Information, Manufacturing Base and Competitors
Table 48. Wong Lo Kat Major Business
Table 49. Wong Lo Kat Nodoame Product and Services
Table 50. Wong Lo Kat Nodoame Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Poon Goor Soe Basic Information, Manufacturing Base and Competitors
Table 52. Poon Goor Soe Major Business
Table 53. Poon Goor Soe Nodoame Product and Services
Table 54. Poon Goor Soe Nodoame Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Guilin Sanjin Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 56. Guilin Sanjin Pharmaceutical Company Limited Major Business
Table 57. Guilin Sanjin Pharmaceutical Company Limited Nodoame Product and Services
Table 58. Guilin Sanjin Pharmaceutical Company Limited Nodoame Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Nodoame Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Nodoame Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Nodoame, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Nodoame Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Nodoame Production Site of Key Manufacturer
Table 64. Nodoame New Entrant and Capacity Expansion Plans
Table 65. Nodoame Mergers & Acquisitions in the Past Five Years
Table 66. Global Nodoame Sales by Region (2017-2022) & (K Units)
Table 67. Global Nodoame Sales by Region (2023-2028) & (K Units)
Table 68. Global Nodoame Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Nodoame Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Nodoame Sales by Type (2017-2022) & (K Units)
Table 71. Global Nodoame Sales by Type (2023-2028) & (K Units)
Table 72. Global Nodoame Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Nodoame Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Nodoame Price by Type (2017-2022) & (USD/Unit)
Table 75. Global Nodoame Price by Type (2023-2028) & (USD/Unit)
Table 76. Global Nodoame Sales by Application (2017-2022) & (K Units)
Table 77. Global Nodoame Sales by Application (2023-2028) & (K Units)
Table 78. Global Nodoame Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Nodoame Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Nodoame Price by Application (2017-2022) & (USD/Unit)
Table 81. Global Nodoame Price by Application (2023-2028) & (USD/Unit)
Table 82. North America Nodoame Sales by Country (2017-2022) & (K Units)
Table 83. North America Nodoame Sales by Country (2023-2028) & (K Units)
Table 84. North America Nodoame Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Nodoame Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Nodoame Sales by Type (2017-2022) & (K Units)
Table 87. North America Nodoame Sales by Type (2023-2028) & (K Units)
Table 88. North America Nodoame Sales by Application (2017-2022) & (K Units)
Table 89. North America Nodoame Sales by Application (2023-2028) & (K Units)
Table 90. Europe Nodoame Sales by Country (2017-2022) & (K Units)
Table 91. Europe Nodoame Sales by Country (2023-2028) & (K Units)
Table 92. Europe Nodoame Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Nodoame Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Nodoame Sales by Type (2017-2022) & (K Units)
Table 95. Europe Nodoame Sales by Type (2023-2028) & (K Units)
Table 96. Europe Nodoame Sales by Application (2017-2022) & (K Units)
Table 97. Europe Nodoame Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Nodoame Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Nodoame Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Nodoame Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Nodoame Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Nodoame Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Nodoame Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Nodoame Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Nodoame Sales by Application (2023-2028) & (K Units)
Table 106. South America Nodoame Sales by Country (2017-2022) & (K Units)
Table 107. South America Nodoame Sales by Country (2023-2028) & (K Units)
Table 108. South America Nodoame Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Nodoame Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Nodoame Sales by Type (2017-2022) & (K Units)
Table 111. South America Nodoame Sales by Type (2023-2028) & (K Units)
Table 112. South America Nodoame Sales by Application (2017-2022) & (K Units)
Table 113. South America Nodoame Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Nodoame Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Nodoame Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Nodoame Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Nodoame Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Nodoame Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Nodoame Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Nodoame Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Nodoame Sales by Application (2023-2028) & (K Units)
Table 122. Nodoame Raw Material
Table 123. Key Manufacturers of Nodoame Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Nodoame Typical Distributors
Table 127. Nodoame Typical Customers
List of Figures
Figure 1. Nodoame Picture
Figure 2. Global Nodoame Revenue Market Share by Type in 2021
Figure 3. Medicinal
Figure 4. Food
Figure 5. Global Nodoame Revenue Market Share by Application in 2021
Figure 6. Supermarket
Figure 7. Drugstore
Figure 8. Global Nodoame Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Nodoame Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Nodoame Sales (2017-2028) & (K Units)
Figure 11. Global Nodoame Price (2017-2028) & (USD/Unit)
Figure 12. Global Nodoame Production Capacity (2017-2028) & (K Units)
Figure 13. Global Nodoame Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Nodoame Market Drivers
Figure 15. Nodoame Market Restraints
Figure 16. Nodoame Market Trends
Figure 17. Global Nodoame Sales Market Share by Manufacturer in 2021
Figure 18. Global Nodoame Revenue Market Share by Manufacturer in 2021
Figure 19. Nodoame Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Nodoame Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Nodoame Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Nodoame Sales Market Share by Region (2017-2028)
Figure 23. Global Nodoame Revenue Market Share by Region (2017-2028)
Figure 24. North America Nodoame Revenue (2017-2028) & (USD Million)
Figure 25. Europe Nodoame Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Nodoame Revenue (2017-2028) & (USD Million)
Figure 27. South America Nodoame Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Nodoame Revenue (2017-2028) & (USD Million)
Figure 29. Global Nodoame Sales Market Share by Type (2017-2028)
Figure 30. Global Nodoame Revenue Market Share by Type (2017-2028)
Figure 31. Global Nodoame Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Nodoame Sales Market Share by Application (2017-2028)
Figure 33. Global Nodoame Revenue Market Share by Application (2017-2028)
Figure 34. Global Nodoame Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Nodoame Sales Market Share by Type (2017-2028)
Figure 36. North America Nodoame Sales Market Share by Application (2017-2028)
Figure 37. North America Nodoame Sales Market Share by Country (2017-2028)
Figure 38. North America Nodoame Revenue Market Share by Country (2017-2028)
Figure 39. United States Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Nodoame Sales Market Share by Type (2017-2028)
Figure 43. Europe Nodoame Sales Market Share by Application (2017-2028)
Figure 44. Europe Nodoame Sales Market Share by Country (2017-2028)
Figure 45. Europe Nodoame Revenue Market Share by Country (2017-2028)
Figure 46. Germany Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Nodoame Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Nodoame Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Nodoame Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Nodoame Revenue Market Share by Region (2017-2028)
Figure 55. China Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Nodoame Sales Market Share by Type (2017-2028)
Figure 62. South America Nodoame Sales Market Share by Application (2017-2028)
Figure 63. South America Nodoame Sales Market Share by Country (2017-2028)
Figure 64. South America Nodoame Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Nodoame Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Nodoame Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Nodoame Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Nodoame Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Nodoame Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Nodoame in 2021
Figure 76. Manufacturing Process Analysis of Nodoame
Figure 77. Nodoame Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のパフ小麦市場2022年：市場規模予測（～2028年）
  • 世界のバタフライパスタソース市場2022年：市場規模予測（～2028年）
  • 世界のパイナップルエッセンス市場2022年：市場規模予測（～2028年）
  • 世界の次元B2ソルト市場2022年：市場規模予測（～2028年）
  • 世界の液体菓子市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO9338 )"世界ののど飴市場2022年：市場規模予測（～2028年）" (英文：Global Nodoame Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。